Fig. 4From: Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study a Incidence density of new-onset dialysis between the treated and untreated cohorts in CKD patients without dialysis; b the treated cohort was subgrouped by therapeutic durationBack to article page